Filing Details
- Accession Number:
- 0001179110-20-004927
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-17 16:02:23
- Reporting Period:
- 2020-04-16
- Accepted Time:
- 2020-04-17 16:02:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1477449 | Teladoc Health Inc. | TDOC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1043027 | Michael Goldstein | C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-16 | 13,105 | $8.71 | 14,023 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-04-16 | 1,700 | $16.64 | 15,723 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-16 | 918 | $165.93 | 14,805 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-16 | 14,805 | $169.13 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-04-16 | 13,105 | $0.00 | 13,105 | $8.71 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-04-16 | 1,700 | $0.00 | 1,700 | $16.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-02-25 | No | 4 | M | Direct | |
| 8,000 | 2026-08-08 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on February 29, 2020.
- Represents the weighted average price of transactions ranging from $166.00 to $171.06. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The option vested as to 25% of the shares on February 25, 2016. The remainder of the shares vested in 36 equal monthly installments thereafter.
- The option vested in full on May 24, 2017.
Billionaire Hedge Funds
